Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
Phase 2
- Conditions
- pruritus in dialysis patients.Other disorders of kidney and ureter, not elsewhere classified
- Registration Number
- IRCT138710291562N1
- Lead Sponsor
- Shiraz University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion Criteria:
Hemodialysis patients > 18 yo suffering from pruritus for at least 6 weeks, and who have not responded to other drugs
Willing and able to give informed concent
Exclusion Criteria
Known dermatologic, liver, metabolic disease, or any other disease or condition other than ESRD that causes pruritus
consumption of antihistamines or other antipruritic drugs
Lactase deficiency
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pruritus. Timepoint: 3 times a week up to 8 weeks. Method of measurement: VAS.
- Secondary Outcome Measures
Name Time Method Tryptase serum level. Timepoint: 8 weeks. Method of measurement: UNICAP.